Medistim ASA (LON: 0OCD)
London
· Delayed Price · Currency is GBP · Price in NOK
148.50
-1.00 (-0.67%)
Jan 27, 2025, 8:35 AM BST
Medistim ASA Revenue
Medistim ASA had revenue of 132.76M NOK in the quarter ending September 30, 2024, with 6.98% growth. This brings the company's revenue in the last twelve months to 541.82M, up 2.83% year-over-year. In the year 2023, Medistim ASA had annual revenue of 521.11M with 7.17% growth.
Revenue (ttm)
541.82M NOK
Revenue Growth
+2.83%
P/S Ratio
n/a
Revenue / Employee
3.59M NOK
Employees
151
Market Cap
208.72M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
Dec 31, 2019 | 356.91M | 33.90M | 10.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |